This pharmaceutical stock, with a three-year CAGR return of 33 per cent, sets a record date for dividends

RPG Life Sciences, a branch of RPG Enterprises, is a global pharmaceutical business with operations in both domestic as well as international markets.

RPG Life Sciences, a branch of RPG Enterprises, is a global pharmaceutical business with operations in both domestic as well as international markets. This company deals in the pharmaceutical sector and has a market capitalisation of Rs 919 crore.  

The company declared a final dividend of Rs 9.60 per equity share for the fiscal year ending March 31, 2022, subject to the approval by the members at the subsequent AGM on July 29, 2022. To determine whether stockholders are qualified to receive the dividend, the company has designated July 15, 2022, as the record date. The dividend will have a dividend value of 120 per cent while the stock has a face value of Rs 8.  

On NSE, the shares of RPG Life Sciences Ltd closed at Rs 557, up from its previous closing of Rs 551.65. The stock price increased from Rs 446.90 on July 5, 2021, to the current level in the previous year, showing a return of 25.31 per cent and a CAGR of almost 25.56 per cent during that time. For the period of the last three years, the stock appreciated from Rs 234.85 on July 4, 2019, to the current level, showing an approximate CAGR of 33.76 per cent and a multibagger">Multi-bagger return of 116 per cent for the same period.   

Last month, it had climbed almost 8 per cent. The stock gained 2 per cent during the last five trading sessions. It reached a 52-week high of Rs 752.45 on September 21, 2021, and a 52-week low of Rs 441.00 on July 1, 2021, indicating that the stock's current price is 26.98 per cent higher than its 52-week high and 25.57 per cent lower than its 52-week low.  

Keep an eye out for the scrip in the upcoming sessions.